Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Finished Dosage Form (FDF) export of Telmisartan obtained from Indian Custom Trade Statistics

    Client Email Product

    Telmisartan

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    130
    US DMFs Filed

    US DMFs Filed

    40
    CEP/COS Certifications

    CEP/COS Certifications

    40
    JDMFs Filed

    JDMFs Filed

    19
    Other Certificates

    Other Certificates

    37
    Other Suppliers

    Other Suppliers

    72
    API REF. PRICE (USD / KG)
    155

    API Market Place

    31
    INTERMEDIATES
    38
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    104
    Europe

    Europe

    354
    Canada

    Canada

    65
    Australia

    Australia

    35
    South Africa

    South Africa

    43
    Uploaded Dossiers

    Uploaded Dossiers

    181
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    386.00

    Annual Reports

    217.00

    FDF Market Place

    12
    EXCIPIENTS
    256
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    5

    News

    41
    REF STANDARD

    EDQM

    3

    USP

    2

    JP

    0

    Other Listed Suppliers

    18
    SERVICES
    2
    left grey arrow
    right gray arrow
    • TABLET;ORAL - 20MG
    • TABLET;ORAL - 40MG
    • TABLET;ORAL - 80MG
    • TABLET;ORAL - 12.5MG;40MG
    • TABLET;ORAL - 12.5MG;80MG
    • TABLET;ORAL - 25MG;80MG
    • TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    left grey arrow
    right gray arrow
    refreshReset Filter
    product-page Product Main Page
    Ask UsAsk Us
    full-view Full Screen View

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    TELMISARTAN 23.53% DIRECTLY COMPRESSIBLEGRANULES

    Supporting Information : Click here to upload a PDF

    165
    138.7
    9,222
    19-Jul-2016
    22,882.2
    1,521,626.7
    Hyderabad ACC (INHYD4)
    30042099
    8943299

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    CILIZEC PLUS (TELMISARTAN 40+HCTZ 12.5)TABLETS (3X10"S PACK)

    Supporting Information : Click here to upload a PDF

    3,270
    1.4
    89.6
    22-Jun-2016
    4,414.5
    292,902.1
    Hyderabad ICD (INSNF6)
    30049099
    8419430

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    TELMISARTAN 23.53%+HYDROCHLOROTHIZADE 3.68%, DC GRANULES

    Supporting Information : Click here to upload a PDF

    80
    153
    9,926.4
    28-Apr-2016
    12,240
    794,109.7
    Hyderabad ACC (INHYD4)
    30042099
    7344423

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    TELMISARTAN 23.53%+HYDROCHLOROTHIZADE 7.35%, DC GRANULES

    Supporting Information : Click here to upload a PDF

    80
    155
    10,056.1
    28-Apr-2016
    12,400
    804,490.3
    Hyderabad ACC (INHYD4)
    30042099
    7344423

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    TELMISARTAN 23.53%+HYDROCHLOROTHIZADE 3.68%, DC GRANULES

    Supporting Information : Click here to upload a PDF

    80
    153
    10,061.2
    15-Apr-2016
    12,240
    804,895.2
    Hyderabad ACC (INHYD4)
    30042099
    7074682

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    TELMISARTAN 23.53%+HYDROCHLOROTHIZADE 7.35%, DC GRANULES

    Supporting Information : Click here to upload a PDF

    80
    155
    10,192.7
    15-Apr-2016
    12,400
    815,416.8
    Hyderabad ACC (INHYD4)
    30042099
    7074682

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    TELMISARTAN+ HYDROCHLOROTHIAZIDE 40MG/12.5MG

    Supporting Information : Click here to upload a PDF

    100
    0
    0.7
    13-Feb-2016
    1
    67.4
    Bombay Air Cargo
    30049079
    5834007

    Finished Dosage Formulations

    Upgrade company profile Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

    TELMISARTAN+ HYDROCHLOROTHIAZIDE 80MG/25MG

    Supporting Information : Click here to upload a PDF

    100
    0
    0.7
    13-Feb-2016
    1
    67.4
    Bombay Air Cargo
    30049079
    5834007
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Octavius Telmisartan

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Aptra Synthesis Telmisartan

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search